Where are we with the management of hypertension? From science to clinical practice

C. Farsang, Lisa Naditch-Brule, Angelo Avogaro, Jan Östergren, Paolo Verdecchia, Aldo Maggioni, Philippe van de Borne, Robert Lins, Alexandre Roca-Cusachs

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The management of elevated blood pressure in patients at high cardiovascular risk is still a subject of debate. The authors review current international guidelines and results of large clinical trials and recent meta-analyses to discuss the different approaches in patients at high risk for cardiovascular events. The different treatment options are considered in view of the modern approach and of the different classes of drugs (diuretics, angiotensin-converting enzyme inhibitors, calcium channel blockers, β-blockers, and angiotensin II receptor blockers) currently in use. A case report is presented as an illustration of the difficulties related to the management of high blood pressure in patients at increased risk. The benefits of the use of 2 medications that include an inhibitor of the renin-angiotensin-aldosterone system and a calcium channel blocker or a diuretic are discussed. Choosing the proper drugs and correct doses are important considerations for the long-term management of hypertension.

Original languageEnglish
Pages (from-to)66-73
Number of pages8
JournalJournal of Clinical Hypertension
Volume11
Issue number2
DOIs
Publication statusPublished - 2009

Fingerprint

Calcium Channel Blockers
Hypertension
Diuretics
Angiotensin Receptor Antagonists
Renin-Angiotensin System
Angiotensin-Converting Enzyme Inhibitors
Pharmaceutical Preparations
Meta-Analysis
Clinical Trials
Guidelines
Blood Pressure
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Farsang, C., Naditch-Brule, L., Avogaro, A., Östergren, J., Verdecchia, P., Maggioni, A., ... Roca-Cusachs, A. (2009). Where are we with the management of hypertension? From science to clinical practice. Journal of Clinical Hypertension, 11(2), 66-73. https://doi.org/10.1111/j.1751-7176.2008.00066.x

Where are we with the management of hypertension? From science to clinical practice. / Farsang, C.; Naditch-Brule, Lisa; Avogaro, Angelo; Östergren, Jan; Verdecchia, Paolo; Maggioni, Aldo; van de Borne, Philippe; Lins, Robert; Roca-Cusachs, Alexandre.

In: Journal of Clinical Hypertension, Vol. 11, No. 2, 2009, p. 66-73.

Research output: Contribution to journalArticle

Farsang, C, Naditch-Brule, L, Avogaro, A, Östergren, J, Verdecchia, P, Maggioni, A, van de Borne, P, Lins, R & Roca-Cusachs, A 2009, 'Where are we with the management of hypertension? From science to clinical practice', Journal of Clinical Hypertension, vol. 11, no. 2, pp. 66-73. https://doi.org/10.1111/j.1751-7176.2008.00066.x
Farsang, C. ; Naditch-Brule, Lisa ; Avogaro, Angelo ; Östergren, Jan ; Verdecchia, Paolo ; Maggioni, Aldo ; van de Borne, Philippe ; Lins, Robert ; Roca-Cusachs, Alexandre. / Where are we with the management of hypertension? From science to clinical practice. In: Journal of Clinical Hypertension. 2009 ; Vol. 11, No. 2. pp. 66-73.
@article{06a8bbe44a8b4a56b1c3e6ed02e960eb,
title = "Where are we with the management of hypertension? From science to clinical practice",
abstract = "The management of elevated blood pressure in patients at high cardiovascular risk is still a subject of debate. The authors review current international guidelines and results of large clinical trials and recent meta-analyses to discuss the different approaches in patients at high risk for cardiovascular events. The different treatment options are considered in view of the modern approach and of the different classes of drugs (diuretics, angiotensin-converting enzyme inhibitors, calcium channel blockers, β-blockers, and angiotensin II receptor blockers) currently in use. A case report is presented as an illustration of the difficulties related to the management of high blood pressure in patients at increased risk. The benefits of the use of 2 medications that include an inhibitor of the renin-angiotensin-aldosterone system and a calcium channel blocker or a diuretic are discussed. Choosing the proper drugs and correct doses are important considerations for the long-term management of hypertension.",
author = "C. Farsang and Lisa Naditch-Brule and Angelo Avogaro and Jan {\"O}stergren and Paolo Verdecchia and Aldo Maggioni and {van de Borne}, Philippe and Robert Lins and Alexandre Roca-Cusachs",
year = "2009",
doi = "10.1111/j.1751-7176.2008.00066.x",
language = "English",
volume = "11",
pages = "66--73",
journal = "Journal of Clinical Hypertension",
issn = "1524-6175",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Where are we with the management of hypertension? From science to clinical practice

AU - Farsang, C.

AU - Naditch-Brule, Lisa

AU - Avogaro, Angelo

AU - Östergren, Jan

AU - Verdecchia, Paolo

AU - Maggioni, Aldo

AU - van de Borne, Philippe

AU - Lins, Robert

AU - Roca-Cusachs, Alexandre

PY - 2009

Y1 - 2009

N2 - The management of elevated blood pressure in patients at high cardiovascular risk is still a subject of debate. The authors review current international guidelines and results of large clinical trials and recent meta-analyses to discuss the different approaches in patients at high risk for cardiovascular events. The different treatment options are considered in view of the modern approach and of the different classes of drugs (diuretics, angiotensin-converting enzyme inhibitors, calcium channel blockers, β-blockers, and angiotensin II receptor blockers) currently in use. A case report is presented as an illustration of the difficulties related to the management of high blood pressure in patients at increased risk. The benefits of the use of 2 medications that include an inhibitor of the renin-angiotensin-aldosterone system and a calcium channel blocker or a diuretic are discussed. Choosing the proper drugs and correct doses are important considerations for the long-term management of hypertension.

AB - The management of elevated blood pressure in patients at high cardiovascular risk is still a subject of debate. The authors review current international guidelines and results of large clinical trials and recent meta-analyses to discuss the different approaches in patients at high risk for cardiovascular events. The different treatment options are considered in view of the modern approach and of the different classes of drugs (diuretics, angiotensin-converting enzyme inhibitors, calcium channel blockers, β-blockers, and angiotensin II receptor blockers) currently in use. A case report is presented as an illustration of the difficulties related to the management of high blood pressure in patients at increased risk. The benefits of the use of 2 medications that include an inhibitor of the renin-angiotensin-aldosterone system and a calcium channel blocker or a diuretic are discussed. Choosing the proper drugs and correct doses are important considerations for the long-term management of hypertension.

UR - http://www.scopus.com/inward/record.url?scp=60549114372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60549114372&partnerID=8YFLogxK

U2 - 10.1111/j.1751-7176.2008.00066.x

DO - 10.1111/j.1751-7176.2008.00066.x

M3 - Article

C2 - 19222670

AN - SCOPUS:60549114372

VL - 11

SP - 66

EP - 73

JO - Journal of Clinical Hypertension

JF - Journal of Clinical Hypertension

SN - 1524-6175

IS - 2

ER -